Zomig package

Notice: Product images are for illustration purposes only and may differ from the medication you receive. Packaging and appearance may vary depending on the country of origin, and generic medications may be supplied by different manufacturers. The medication, strength, and active ingredients will match your prescription. At the Canadian Pharmacy Store we prioritize your health and safety by working with licensed pharmacy partners to provide safe, high-quality medications.

Zomig (Zolmitriptan)

Generic:Zolmitriptan

Zomig

Zolmitriptan

Sourced from Canada Source: Canada
Prescription Required
Select product strength & quantity:

Zomig Nasal Spray

Zolmitriptan

Sourced from Canada Source: Canada
Prescription Required
Select product strength & quantity:

Zomig-ZMT

Zolmitriptan

Sourced from Canada Source: Canada
Prescription Required
Select product strength & quantity:
Select Strength & Quantity

Choose the strength, form, and package size that match your prescription.

Send Your Prescription

Upload your prescription online, request a transfer, or have your doctor fax us.

Pharmacist Review & Delivery

Reviewed by a licensed pharmacist and shipped to your U.S. address with tracking. Shipping details.

Description

Zomig (zolmitriptan) is a serotonin-1b and serotonin-1d receptor agonist listed in our Neurology medications directory and prescribed for migraine (1.1) (2.1). Administered via the oral route, Zomig is available for delivery to U.S. residents through Canadian Pharmacy Store with a valid prescription. Review the clinical fact table, dosage directions, cautions, drug interactions, side effects, and official regulatory sources below.

Zomig is a medication containing the active pharmaceutical ingredient zolmitriptan, classified pharmacologically as a serotonin-1b and serotonin-1d receptor agonist (2.1). It is clinically indicated for the management of migraine as part of a comprehensive treatment plan supervised by a licensed healthcare provider (2.1).

Within the Neurology medications section of our catalogue, patients and prescribers frequently review Zomig alongside related therapies such as Zolmitriptan, Almotriptan, Amantadine Hydrochloride, and Aricept (Donepezil Hydrochloride).

Official Indications and Usage

Zomig is indicated for the acute treatment of migraine with or without aura in adults.

Limitations of use: Only use Zomig if a clear diagnosis of migraine has been established. If a patient has no response to Zomig treatment for the first migraine attack, reconsider the diagnosis of migraine before Zomig is administered to treat any subsequent attacks. Zomig is not indicated for the prevention of migraine attacks. Safety and effectiveness of Zomig have not been established for cluster headache. (1.1)

Mechanism of Action and Pharmacology

Zolmitriptan binds with high affinity to human recombinant 5-HT 1D and 5‑HT 1B receptors, and moderate affinity for 5-HT 1A receptors. The N-desmethyl metabolite also has high affinity for 5‑HT 1B/1D and moderate affinity for 5‑HT 1A receptors. Migraines are likely due to local cranial vasodilatation and/or to the release of sensory neuropeptides (vasoactive intestinal peptide, substance P and calcitonin gene-related peptide) through nerve endings in the trigeminal system. The therapeutic activity of Zomig for the treatment of migraine headache is thought to be due to the agonist effects at the 5‑HT 1B/1D receptors on intracranial blood vessels (including the arterio-venous anastomoses) and sensory nerves of the trigeminal system which result in cranial vessel constriction and inhibition of pro-inflammatory neuropeptide release. (1.1)

What is Migraine?

Migraine can cause recurrent headache and other neurologic symptoms. Medicines used during an attack and medicines used for prevention serve different purposes. Explore related medications below and discuss treatment options with your healthcare provider. Read our complete Migraine condition guide for appointment questions and related therapies (2.1).

Ordering Zomig from Canada for U.S. Delivery

U.S. patients can order Zomig (Zolmitriptan) in U.S. dollars with a valid prescription from a U.S.-licensed clinician. Your card is only charged after your prescription passes pharmacist safety checks and is ready to ship.

Step 1

Send Your Prescription

Step 2

Pharmacist Safety Check

  • Multi-point dosing and interaction review completed in under 1 business day.
  • Mandatory licensed pharmacist consultation via phone, voicemail, or text before dispatch.
  • Verified under our Pharmacy Safety Standards.
Step 3

$14.99 USD Tracked Parcel

  • Packed in discreet protective packaging for a flat $14.99 USD per order ($29.99 if combined with cold-chain).
  • Tracked via Canada Post and USPS: 3 to 7 business days from Canada (7 to 14 days from international partners).
  • Review full shipping and delivery details.
Step 4

U.S. Street Delivery & Payment

  • Delivered to any physical U.S. street address with signature upon delivery (no P.O. Boxes).
  • You see and approve the country of origin upfront before your card is charged.
  • Report any delayed or damaged parcel within 48 hours for prompt resolution.

Fact Table

Clinical Specification Details
Brand / Product Name Zomig
Chemical / Generic Name Zolmitriptan
Pharmacological Class Serotonin-1b and Serotonin-1d Receptor Agonist
Therapeutic Category Neurology medications
Molecular Weight 287.36. g/mol (2.1)
Bioavailability ~40% (1.1)
Protein Binding ~25% (1.1)
Legal Status Rx-Only (Prescription Required)
Regulatory Reference Authorities U.S. FDA (DailyMed), Health Canada (DPD), NLM MedlinePlus
Routes of Administration Oral
Dosage Forms & Strengths 2.5 mg Tablets: Yellow colored, round, biconvex film-coated tablets debossed with 101 on one side and deep breakline on other side. 5 mg Tablets: Pink
Primary Indications Migraine
Pregnancy & Breastfeeding Consult Doctor / Prescriber before use
FDA UNII Identifier 2FS66TH3YW
NLM RxNorm Concept ID (RxCUI) 153353, 200193, 200194, 213167
FDA Application License ANDA207867
Official DailyMed SetID 1d977430-f494-415d-9daf-3c3163156249
Catalogue Index Links Letter Z Index · All Medications · All Categories

Directions

Dosage and Administration Overview

Recommended starting dose: 1.25 mg or 2.5 mg Maximum single dose: 5 mg May repeat dose after 2 hours if needed; not to exceed 10 mg in any 24-hour period Moderate or Severe Hepatic Impairment: 1.25 mg recommended. (1.1)

Presentations and Strengths

2.5 mg Tablets: Yellow colored, round, biconvex film-coated tablets debossed with 101 on one side and deep breakline on other side. 5 mg Tablets: Pink colored, round, biconvex film-coated tablets debossed with 102 on one side and plain on the other side. Tablets: 2.5 mg functionally-scored Tablets: 5 mg (not scored). (1.1)

Administration Guidance

Take Zomig orally at the same time(s) each day as directed on your prescription label (1.1). Check with your pharmacist whether your specific formulation should be taken with a meal or on an empty stomach, and swallow extended-release or film-coated tablets whole without crushing, chewing, or splitting unless the tablet is scored and your prescriber has instructed you to do so.

Missed Dose Guidance

If you miss a scheduled dose of Zomig, follow the missed-dose instructions in the official patient leaflet or ask your pharmacist. Do not double the next dose to make up for a missed dose (2.1).

Ingredients

Active Pharmaceutical Ingredient

The active ingredient in Zomig is zolmitriptan (2.1).

Excipients and Formulation Carriers

Film coatings, stabilizers, and inactive carriers vary by strength and manufacturer presentation. If you have a known allergy to lactose, dyes, sulfites, or specific preservatives, ask our pharmacist to check the exact excipient list for your selected package (2.1).

Cautions and important safety information

Contraindications

Zomig is contraindicated in patients with: Ischemic coronary artery disease (angina pectoris, history of myocardial infarction, or documented silent ischemia), other significant underlying cardiovascular disease, or coronary artery vasospasm including Prinzmetal’s angina. Wolff-Parkinson-White Syndrome or arrhythmias associated with other cardiac accessory conduction pathway disorders. History of stroke, transient ischemic attack (tia), or history of hemiplegic or basilar migraine because these patients are at a higher risk of stroke. Peripheral vascular disease (pvd). Ischemic bowel disease. (1.1)

Key Clinical Precautions

Before starting or continuing Zomig, discuss your complete medical history with your healthcare provider. Key clinical cautions include (1.1):

  • Cardiovascular events: Depending on the medication class and underlying medical history, patients should be monitored for signs of cardiovascular events such as chest pain, shortness of breath, sudden weakness, or slurred speech.
  • Hemorrhage and bleeding risk: Anticoagulant, antiplatelet, or gastrointestinal-affecting therapies can increase the risk of serious or fatal bleeding. Report unusual bruising, nosebleeds, blood in urine or stools, black tarry stools, or coughing up blood immediately.
  • Serotonin syndrome: Concomitant use with other serotonergic agents (SSRIs, SNRIs, triptans, MAOIs, linezolid, tramadol, or St. John’s wort) can precipitate potentially life-threatening serotonin syndrome (agitation, rapid heart rate, muscle twitching, fever).
  • Blood pressure elevation: Monitor blood pressure regularly during treatment and inform your clinician if sustained increases occur.

Pregnancy, Lactation, and Special Populations

There are no adequate data on the developmental risk associated with the use of Zomig in pregnant women. In reproductive toxicity studies in rats and rabbits, oral administration of zolmitriptan to pregnant animals resulted in embryolethality and fetal abnormalities (malformations and variations) at clinically relevant exposures. In the U.S. General population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. (1.1)

Interactions

Official Drug Interaction Overview

Drugs Ergot-containing drugs have been reported to cause prolonged vasospastic reactions. Because these effects may be additive, use of ergotamine-containing or ergot-type medications (like dihydroergotamine or methysergide) and Zomig within 24 hours of each other is contraindicated. (1.1)

Important Interaction Categories

Concomitant use of Zomig with certain prescription medications, over-the-counter drugs, or supplements can alter how the medication works or increase the risk of side effects. Important interaction categories to review with your prescriber and pharmacist include (2.1):

  • Monoamine oxidase inhibitors (MAOIs, such as phenelzine, tranylcypromine, selegiline, or linezolid): Concomitant use or use within 14 days of stopping an MAOI can cause severe drug interactions, including hypertensive crisis, serotonin syndrome, or enhanced hypoglycemic and central nervous system effects.

Side effects

Like all medications, Zomig can cause side effects, although not everyone experiences them. Commonly reported side effects in clinical trials and official labeling include (1.1):

  • Nausea (feeling sick): Often mild to moderate and most noticeable when starting therapy or increasing the dose; taking oral doses with food (when permitted by the label) may help.
  • Headache: Commonly reported during initial treatment; often improves as your body adjusts to the medication.
  • Dizziness or lightheadedness: May occur especially when standing up quickly from a sitting or lying position (orthostatic changes); rise slowly and stay well hydrated.
  • Drowsiness or somnolence: Use caution with driving or tasks requiring alertness until you know how this medication affects you.
  • Insomnia or sleep disturbances: Taking morning doses earlier in the day (if consistent with your prescription) may reduce nighttime restlessness.
  • Xerostomia (dry mouth): Sipping water or using sugar-free lozenges can help relieve oral dryness.

Clinical Trial and Postmarketing Adverse Reactions

The following adverse reactions are described elsewhere in other sections of the prescribing information: Myocardial Ischemia, Myocardial Infarction, and Prinzmetal’s Angina. Arrhythmias. Chest and or Throat, Neck and Jaw Pain/Tightness/Pressure. Cerebrovascular Events. Other Vasospasm Reactions. (1.1)

When to Seek Immediate Medical Attention

Contact your physician or seek urgent medical care if you experience signs of a severe allergic reaction (hives, difficulty breathing, or swelling of the face, lips, tongue, or throat), severe dizziness or fainting, unexplained severe pain, or any sudden change in your clinical symptoms (2.1).

Storage and handling

  • Yellow colored, round, biconvex film-coated tablets, debossed with 101 on one side and deep breakline on other side and are supplied in carton of 6 (1 x 6) unit-dose tablets (NDC 60846-130-30). Store Zomig Tablets between 20º to 25ºC (68º to 77ºF). Protect from light and moisture. (1.1)

Store Zomig in its original container at controlled room temperature away from excess heat, direct light, and moisture (such as bathroom cabinets), and keep out of reach of children and pets (1.1).

What is a generic drug?

A generic medication contains the exact same active pharmaceutical ingredient (zolmitriptan) as its brand-name counterpart and is formulated to deliver the same dosage strength, route of administration, safety profile, quality, and therapeutic performance (2.1). Regulatory authorities require generic manufacturers to demonstrate bioequivalence, meaning the generic medication releases its active ingredient into the bloodstream at virtually the same rate and to the same extent as the innovator brand.

While a generic tablet, capsule, or inhaler may differ in color, shape, scoring, or packaging due to trademark laws that govern brand appearance, its clinical mechanism and active ingredient match the reference medicine. Because generic manufacturers do not repeat the initial discovery and multi-phase clinical trial investments of the original brand, generic equivalents offer substantial cost savings for patients paying out of pocket.

Canadian Pharmacy Store delivers prescription and over-the-counter medications to U.S. residents. Browse our Neurology medications directory, explore all medications A-Z, review how ordering works and prescription requirements, or call 1-888-868-1920 for personal assistance matching your prescription.

Frequently Asked Questions About Zomig

What is Zomig and what active ingredient does it contain?

Zomig is a serotonin-1b and serotonin-1d receptor agonist containing the active pharmaceutical ingredient zolmitriptan. It is supplied for oral administration and requires a valid prescription where applicable.

How does Zomig work in the body?

Zolmitriptan binds with high affinity to human recombinant 5-HT 1D and 5‑HT 1B receptors, and moderate affinity for 5-HT 1A receptors. The N-desmethyl metabolite also has high affinity for 5‑HT 1B/1D and moderate affinity for 5‑HT 1A receptors. Migraines are likely due to local cranial vasodilatation and/or to the release of sensory neuropeptides (vasoactive intestinal peptide, substance P and calcitonin gene-related peptide) through nerve endings in the trigeminal system.

What conditions is Zomig prescribed to treat?

Zomig is primarily indicated for migraine. Your prescribing clinician determines the appropriate indication, strength, and treatment duration based on your individual diagnosis and medical history.

How should I take or use Zomig?

Follow the exact dosage, frequency, and administration instructions printed on your prescription label. Zomig is administered via the oral route. Take it consistently at the same time(s) as directed, and never adjust your dose or stop therapy without speaking with your prescriber.

What are the most common side effects of Zomig?

Commonly reported side effects of Zomig include feeling sick, headache, dizziness, sleepiness, difficulty sleeping, and dry mouth. Most mild side effects improve as your body adjusts to treatment, but you should notify your doctor or pharmacist if symptoms persist or worsen.

What medications or substances can interact with Zomig?

Important interaction categories for Zomig include monoamine oxidase inhibitors. Always share a complete list of your prescription drugs, over-the-counter medicines, vitamins, and herbal supplements with your pharmacist before starting treatment.

Can Zomig be used during pregnancy or breastfeeding?

If you are pregnant, planning to become pregnant, or breastfeeding, consult your prescribing physician before using Zomig to weigh the clinical benefits and potential risks.

Do I need a prescription to buy Zomig online from Canada?

Yes. A valid prescription written by a U.S.-licensed physician, nurse practitioner, or physician assistant is required to buy Zomig (Zolmitriptan) through our licensed Canadian pharmacy partners. Valid prescriptions go through multiple safety checks in less than 1 business day, followed by a mandatory request to speak with a licensed pharmacist for a consultation (watch your phone, voicemails, and text messages).

Does Zomig have a generic equivalent (Zolmitriptan) at a Canada pharmacy?

Yes. A lower-cost generic equivalent (Zolmitriptan) containing Zolmitriptan is available alongside brand-name Zomig in our Canada pharmacy catalogue.

How is Zomig shipped to U.S. residents, and how much does shipping cost?

Zomig ships in discreet protective packaging at a flat rate of $14.99 USD per order via Canada Post and USPS with full tracking (if combined in the same order with a cold-chain item, total shipping is $29.99 USD in a larger container). Once your valid prescription passes safety checks (<1 business day) and you respond to the mandatory licensed pharmacist consultation request via phone, voicemail, or text message, delivery takes 3 to 7 business days from Manitoba, Canada (or 7 to 14 business days from licensed partner pharmacies in the UK, Singapore, and Mauritius). You see and choose the country of origin before you pay, and your Visa, Mastercard, or Discover card is only charged when your order is ready to ship.

How can I send or transfer my Zomig prescription, or ask about an unlisted strength?

You can upload a clear photo or PDF of your Zomig prescription online, request a prescription transfer or direct prescriber coordination from our team, or have your prescriber fax the prescription directly to (844) 666 – 6819. You may order up to a 90-day personal-use supply per shipment. If you do not see your exact prescribed strength or manufacturer listed, call 1-888-868-1920 and our staff will check availability across our licensed pharmacy partners.

References & Official Sources

Clinical, pharmacological, and safety facts for Zomig (Zolmitriptan) are compiled directly from official regulatory prescribing labels and primary biomedical databases:

  1. (1.1) Zomig (Zolmitriptan), Official Prescribing Information. U.S. National Library of Medicine / U.S. Food and Drug Administration (DailyMed). Official U.S. FDA / DailyMed Structured Product Labeling (SPL). (Accessed 2026-10-29).
  2. (2.1) MedlinePlus Medical Encyclopedia: Migraine. MedlinePlus / National Library of Medicine. U.S. National Library of Medicine, MedlinePlus Drug & Health Information. (Accessed 2026-10-29).
  3. (3.1) Health Canada Drug Product Database (DPD), Authorized Product Records. Health Canada / Government of Canada. Health Canada Drug Product Database & Official Product Monograph. (Accessed 2026-10-29).

Related Condition Guides

Related Guides

Call 1-888-868-1920Help